Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL
Abstract
Key Points Accurate GZL diagnosis remains challenging, with >60% of patients with presumed GZL having the diagnosis reclassified on consensus review. Treatment with DLBCL-based therapy appears most effective for GZL (including R-CHOP); however, new therapies are needed to improve...
Paper Details
Title
Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL
Published Date
Dec 11, 2017
Journal
Volume
1
Issue
26
Pages
2600 - 2609
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History